Channel 10 franchise extended 4 years

The Knesset economics committee gave its approval to extend Channel 10's franchise for four years in a second and third reading of the committee on Monday.

By AVI KRAWITZ
November 1, 2005 07:58

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Knesset economics committee gave its approval to extend Channel 10's franchise for four years in a second and third reading of the committee on Monday. The decision gives Channel 10 broadcasting rights until 2014, the economics committee said in a statement, provided that the channel fulfills its production obligations in the next two years. The committee also gave its approval for the rescheduling of the company's debt, giving it until 2010 to pay unmet obligations from 2004 and 2005. The committee stressed that the structure of payments did not apply to future debts accrued in 2006 and 2007, as the original law had included next year in the structure.



More about:Knesset

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS